🔎 Trials Near Me

Akèy › Maladi Parkinson › Kalifòni › Mountain View

Etid klinik pou Maladi Parkinson nan Mountain View, CA

9 etid pou Maladi Parkinson ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Ap rekriteFaz 2
  • Parkinson's Research Centers of America - Palo Alto, Palo Alto · 5 mi lwen
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830

GBPDC: Gut-Brain in PD Consortium Master Protocol

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Stanford University, Stanford · 5 mi lwen
Laj 21 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07567794

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Ap rekriteFaz 2
  • Parkinson's Research Centers of America (Site #218), Palo Alto · 5 mi lwen
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Ap rekriteFaz 3
  • Parkinson?s Research Centers of America ? Palo Alto, Palo Alto · 5 mi lwen
  • Stanford Neuroscience Health Center (SNHC), Stanford · 5 mi lwen
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Ap rekriteFaz 3
  • Stanford Neuroscience Health Center, Palo Alto · 5 mi lwen
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

Ap rekriteEtid obsèvasyon
  • Parkinson's Research Centers of America - Palo Alto, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 22, 2025 · NCT07219927

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Ap rekriteFaz 4
  • Parkinson's Research Centers of America - Palo Alto, Palo Alto · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668

Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease

Ap rekrite
  • Stanford Neuroscience Health Center, Stanford · 5 mi lwen
Laj 21 a 80 · Tout sèks · Mizajou May 30, 2025 · NCT05968703

Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Stanford University, Stanford · 5 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou May 2, 2025 · NCT05395624

Etid Maladi Parkinson nan lòt vil

Lòt etid nan Mountain View

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.